Research Articles
Meat and Heme Iron Intake and Risk of Squamous Cell Carcinoma of the Upper Aero-Digestive Tract in the European Prospective Investigation into Cancer and Nutrition (EPIC)
Annika Steffen, Manuela M. Bergmann, María-José Sánchez, Maria-Dolores Chirlaque, Paula Jakszyn, Pilar Amiano, J. Ramón Quirós, Aurelio Barricarte Gurrea, Pietro Ferrari, Isabelle Romieu, Veronika Fedirko, H. B(as). Bueno-de-Mesquita, Peter D. Siersema, Petra H.M. Peeters, Kay-Tee Khaw, Nick Wareham, Naomi E. Allen, Francesca L. Crowe, Guri Skeie, Göran Hallmanns, Ingegerd Johansson, Signe Borgquist, Ulrika Ericson, Rikke Egeberg, Anne Tjønneland, Kim Overvad, Verena Grote, Kuanrong Li, Antonia Trichopoulou, Despoina Oikonomidou, Menelaos Pantzalis, Rosario Tumino, Salvatore Panico, Domenico Palli, Vittorio Krogh, Alessio Naccarati, Traci Mouw, Anne-Claire Vergnaud, Teresa Norat and Heiner Boeing
Annika Steffen
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
Manuela M. Bergmann
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
María-José Sánchez
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
Maria-Dolores Chirlaque
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
Paula Jakszyn
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
Pilar Amiano
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
J. Ramón Quirós
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
Aurelio Barricarte Gurrea
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
Pietro Ferrari
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
Isabelle Romieu
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
Veronika Fedirko
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
H. B(as). Bueno-de-Mesquita
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
Peter D. Siersema
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
Petra H.M. Peeters
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
Kay-Tee Khaw
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
Nick Wareham
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
Naomi E. Allen
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
Francesca L. Crowe
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
Guri Skeie
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
Göran Hallmanns
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
Ingegerd Johansson
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
Signe Borgquist
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
Ulrika Ericson
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
Rikke Egeberg
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
Anne Tjønneland
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
Kim Overvad
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
Verena Grote
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
Kuanrong Li
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
Antonia Trichopoulou
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
Despoina Oikonomidou
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
Menelaos Pantzalis
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
Rosario Tumino
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
Salvatore Panico
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
Domenico Palli
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
Vittorio Krogh
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
Alessio Naccarati
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
Traci Mouw
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
Anne-Claire Vergnaud
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
Teresa Norat
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
Heiner Boeing
1Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany; 2Andalusian School of Public Health, Granada, Spain; 3Department of Epidemiology, Regional Health Authority, Murcia, Spain; 4Unit of Nutrition, Environment and Cancer, Catalan Institute of Oncology (ICO-Idibell), Barcelona, Spain; 5Public Health Division of Gipuzkoa, BIODonostia Research Institute, Department of Health of the regional Government of the Basque Country, San Sebastian, Spain; 6Public Health and Health Planning Directorate, Asturias, Spain; 7Navarre Public Health Institute, Pamplona, Spain; 8CIBER Epidemiología y Salud Pública (CIBERESP), Spain; 9International Agency for Research on Cancer (IARC), Lyon, France; 10National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; 11Department of Gastroenterology and Hepatology, 12Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands; 13Department of Public Health and Primary Care, University of Cambridge; 14MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom; 15Clinical Trial Service Unit and Epidemiological Studies Unit, 16Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom; 17Department of Community Medicine, University of Tromsø, Norway; 18Department of Public Health and Clinical Medicine, Nutritional Research, 19Department of Odontology, Umeå University, Umeå, Sweden; 20Department of Oncology, Clinical Sciences, Skåne University Hospital, Sweden; 21Diabetes and Cardiovascular disease, Genetic Epidemiology Department of Clinical Sciences in Malmö, Lund University, Sweden; 22Danish Cancer Society Research Center, Copenhagen, Denmark; 23Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark; 24Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; 25WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School; 26Hellenic Health Foundation, Athens Greece; 27Cancer Registry and Histopathology Unit, “Civile - M.P. Arezzo” Hospital, Ragusa, Italy; 28Department of Clinical and Experimental Medicine, Frederico II University, Naples, Italy; 29Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence, Italy; 30Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 31HuGeF - Human Genetics Foundation - Torino, Molecular and Genetic Epidemiology Unit, Torino, Italy; and 32Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
DOI: 10.1158/1055-9965.EPI-12-0835 Published December 2012
Abstract
Background: Evidence from prospective studies on intake of meat and fish and risk of squamous cell carcinoma (SCC) of the upper aero-digestive tract (UADT) is scarce. We prospectively investigated the association of meat and fish intake with risk of SCC of the UADT and the possible mechanism via heme iron in the large multicenter European Prospective Investigation into Cancer and Nutrition (EPIC) study.
Methods: Multivariable proportional hazards models were used to estimate relative risks (RR) of SCC of the UADT in relation to intake of total meat, as well as subtypes of meat, fish, and heme iron among 348,738 individuals from 7 European countries.
Results: During an average follow-up of 11.8 years, a total of 682 incident cases of UADT SCC were accrued. Intake of processed meat was positively associated with risk of SCC of the UADT in the total cohort [highest vs. lowest quintile: RR = 1.41; 95% confidence interval (CI) = 1.03–1.94], however, in stratified analyses, this association was confined to the group of current smokers (highest vs. lowest quintile: RR = 1.89; 95% CI = 1.22–2.93). Red meat, poultry, fish, and heme iron were not consistently related to UADT SCC.
Conclusion: Higher intake of processed meat was positively associated with SCC of the UADT among smokers. Although this finding was stable in various sensitivity analyses, we cannot rule out residual confounding by smoking. Confirmation in future studies and identification of biologic mechanisms is warranted.
Impact: Smokers may further increase their risk for SCC of the UADT if they additionally consume large amounts of processed meat. Cancer Epidemiol Biomarkers Prev; 21(12); 2138–48. ©2012 AACR.
This article is featured in Highlights of This Issue, p. 2123
- Received July 17, 2012.
- Revision received September 20, 2012.
- Accepted September 24, 2012.
- ©2012 American Association for Cancer Research.
December 2012
Volume 21, Issue 12
Volume 21, Issue 12
Meat and Heme Iron Intake and Risk of Squamous Cell Carcinoma of the Upper Aero-Digestive Tract in the European Prospective Investigation into Cancer and Nutrition (EPIC)
Annika Steffen, Manuela M. Bergmann, María-José Sánchez, Maria-Dolores Chirlaque, Paula Jakszyn, Pilar Amiano, J. Ramón Quirós, Aurelio Barricarte Gurrea, Pietro Ferrari, Isabelle Romieu, Veronika Fedirko, H. B(as). Bueno-de-Mesquita, Peter D. Siersema, Petra H.M. Peeters, Kay-Tee Khaw, Nick Wareham, Naomi E. Allen, Francesca L. Crowe, Guri Skeie, Göran Hallmanns, Ingegerd Johansson, Signe Borgquist, Ulrika Ericson, Rikke Egeberg, Anne Tjønneland, Kim Overvad, Verena Grote, Kuanrong Li, Antonia Trichopoulou, Despoina Oikonomidou, Menelaos Pantzalis, Rosario Tumino, Salvatore Panico, Domenico Palli, Vittorio Krogh, Alessio Naccarati, Traci Mouw, Anne-Claire Vergnaud, Teresa Norat and Heiner Boeing
Cancer Epidemiol Biomarkers Prev December 1 2012 (21) (12) 2138-2148; DOI: 10.1158/1055-9965.EPI-12-0835
Meat and Heme Iron Intake and Risk of Squamous Cell Carcinoma of the Upper Aero-Digestive Tract in the European Prospective Investigation into Cancer and Nutrition (EPIC)
Annika Steffen, Manuela M. Bergmann, María-José Sánchez, Maria-Dolores Chirlaque, Paula Jakszyn, Pilar Amiano, J. Ramón Quirós, Aurelio Barricarte Gurrea, Pietro Ferrari, Isabelle Romieu, Veronika Fedirko, H. B(as). Bueno-de-Mesquita, Peter D. Siersema, Petra H.M. Peeters, Kay-Tee Khaw, Nick Wareham, Naomi E. Allen, Francesca L. Crowe, Guri Skeie, Göran Hallmanns, Ingegerd Johansson, Signe Borgquist, Ulrika Ericson, Rikke Egeberg, Anne Tjønneland, Kim Overvad, Verena Grote, Kuanrong Li, Antonia Trichopoulou, Despoina Oikonomidou, Menelaos Pantzalis, Rosario Tumino, Salvatore Panico, Domenico Palli, Vittorio Krogh, Alessio Naccarati, Traci Mouw, Anne-Claire Vergnaud, Teresa Norat and Heiner Boeing
Cancer Epidemiol Biomarkers Prev December 1 2012 (21) (12) 2138-2148; DOI: 10.1158/1055-9965.EPI-12-0835
Jump to section
Advertisement